Albemarle will keep catalysts unit as a subsidiary, reorganize its lithium and bromine businesses By / On September 1, 2022 / At 10:10 pm / In Chemical world 7 Views Post Content Post navigation Prev PostNovartis slapped with patent suit for blockbuster drug Next PostVilya launches out of Baker lab with $50 million You May Also Like Ammonia fuel project set for Japan On September 26, 2022 | In Chemical world Decarbonization is industry opportunity, report says On September 26, 2022 | In Chemical world Making drugs more bioavailable On September 25, 2022 | In Chemical world
By 